{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:27:23Z","timestamp":1790785643961,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":883,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1002\/hep.26359","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T14:18:23Z","timestamp":1362493103000},"page":"1651-1653","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":622,"title":["Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012"],"prefix":"10.1097","volume":"57","author":[{"given":"Bruce A.","family":"Runyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-37-20241202","doi-asserted-by":"crossref","first-page":"122128","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors.","volume":"7","author":"Gines","year":"1987","journal-title":"HEPATOLOGY"},{"key":"R2-37-20241202","doi-asserted-by":"crossref","first-page":"215220","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serumascites albumin gradient is superior to the exudatetransudate concept in the differential diagnosis of ascites.","volume":"117","author":"Runyon","year":"1992","journal-title":"Ann Intern Med"},{"key":"R3-37-20241202","first-page":"193194","article-title":"Reexamining the physical examination for obese patients.","volume":"305","author":"Silk","year":"2011","journal-title":"JAMA"},{"key":"R4-37-20241202","doi-asserted-by":"crossref","first-page":"11351145","DOI":"10.1016\/j.jhep.2010.08.001","article-title":"Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.","volume":"53","author":"Sola","year":"2010","journal-title":"J Hepatol"},{"key":"R5-37-20241202","doi-asserted-by":"crossref","first-page":"482487","DOI":"10.1016\/0016-5085(88)90441-6","article-title":"Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.","volume":"94","author":"Llach","year":"1988","journal-title":"Gastroenterology"},{"key":"R6-37-20241202","doi-asserted-by":"crossref","first-page":"12551259","DOI":"10.1016\/S0016-5085(85)80088-3","article-title":"Acute effects of catopril on systemic hemodynamics and on renal function in cirrhotic patients with ascites.","volume":"88","author":"Pariente","year":"1985","journal-title":"Gastroenterology"},{"key":"R7-37-20241202","first-page":"397417","article-title":"EASL clinical practice guideline on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome.","volume":"53","author":"Gines","year":"2010","journal-title":"J Hepatol"},{"key":"R8-37-20241202","doi-asserted-by":"crossref","first-page":"10171022","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of betablockers on survival in patients with cirrhosis and refractory ascites.","volume":"52","author":"Serste","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R9-37-20241202","doi-asserted-by":"crossref","first-page":"794799","DOI":"10.1016\/j.jhep.2011.01.034","article-title":"Betablockers cause paracentesisinduced circulatory dysfunction in patients with cirrhosis and refractory ascites: a crossover study.","volume":"55","author":"Serste","year":"2011","journal-title":"J Hepatol"},{"key":"R10-37-20241202","first-page":"566567","article-title":"Hepatic hydrothorax is a relative contraindication to chest tube insertion.","volume":"81","author":"Runyon","year":"1986","journal-title":"Arch Intern Med"},{"key":"R11-37-20241202","doi-asserted-by":"crossref","first-page":"582586","DOI":"10.1007\/s12072-009-9136-z","article-title":"Outcomes of patients with chest tube insertion for hepatic hydrothorax.","volume":"3","author":"Orman","year":"2009","journal-title":"Hepatol Int"},{"key":"R12-37-20241202","doi-asserted-by":"crossref","first-page":"10721075","DOI":"10.1016\/j.gie.2010.06.043","article-title":"Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series.","volume":"72","author":"Baltz","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"R13-37-20241202","doi-asserted-by":"crossref","first-page":"19151922","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcoholdependent patients with liver cirrhosis: randomized, doubleblind controlled study.","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"R14-37-20241202","first-page":"1091A","article-title":"The GABAB agonist baclofen improves alcohol consumption, psychometrics and may have an effect on the hospital admission rates of patients with alcoholic liver disease.","volume":"56","author":"Heydtmann","year":"2012","journal-title":"HEPATOLOGY"},{"key":"R15-37-20241202","doi-asserted-by":"crossref","first-page":"17161722","DOI":"10.1001\/jama.2010.533","article-title":"Relationship between early physician followup and 30day redmission among Medicare beneficiaries hospitalized for heart failure.","volume":"303","author":"Hernandez","year":"2010","journal-title":"JAMA"},{"key":"R16-37-20241202","first-page":"36313635","article-title":"Spot urine sodium for assessing dietary sodium restriction in cirrhotic ascites.","volume":"15","author":"ElBokl","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R17-37-20241202","doi-asserted-by":"crossref","first-page":"108116","DOI":"10.1136\/gutjnl-2011-300157","article-title":"Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity.","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"R18-37-20241202","doi-asserted-by":"crossref","first-page":"348354","DOI":"10.1016\/j.jhep.2011.04.027","article-title":"Midodrine in patients with cirrhosis and refractory ascites: a randomized pilot study.","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"key":"R19-37-20241202","doi-asserted-by":"crossref","first-page":"11721181","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing largevolume paracentesis: a metaanalysis of randomized trials.","volume":"55","author":"Bernardi","year":"2012","journal-title":"HEPATOLOGY"},{"key":"R20-37-20241202","doi-asserted-by":"crossref","first-page":"15511561","DOI":"10.1002\/hep.25532","article-title":"Prevalence and risk factors of infections by resistant bacteria in cirrhosis: a prospective study.","volume":"55","author":"Fernandez","year":"2012","journal-title":"HEPATOLOGY"},{"key":"R21-37-20241202","doi-asserted-by":"crossref","first-page":"825832","DOI":"10.1016\/j.jhep.2011.11.010","article-title":"Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare, and nosocomial spontaneous bacterial peritonitis.","volume":"56","author":"Ariza","year":"2012","journal-title":"J Hepatol"},{"key":"R22-37-20241202","doi-asserted-by":"crossref","first-page":"12451246","DOI":"10.1111\/j.1478-3231.2010.02337.x","article-title":"Changing flora of bacterial infections in patients with cirrhosis.","volume":"30","author":"Runyon","year":"2010","journal-title":"Liver Int"},{"key":"R23-37-20241202","doi-asserted-by":"crossref","first-page":"23622370","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R24-37-20241202","doi-asserted-by":"crossref","first-page":"267273","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinaseassociated lipocalin as a biomarker in the differential diagnosis of impairment of kidney function in cirrhosos.","volume":"57","author":"Fagundes","year":"2012","journal-title":"J Hepatol"},{"key":"R25-37-20241202","doi-asserted-by":"crossref","first-page":"576584","DOI":"10.1002\/hep.23286","article-title":"Systemic review of randomized trials of vasoconstrictor drugs for hepatorenal syndrome.","volume":"51","author":"Gluud","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R26-37-20241202","doi-asserted-by":"crossref","first-page":"724728","DOI":"10.1002\/hep.24519","article-title":"Terlipressin: an asset for hepatologists.","volume":"54","author":"Sarin","year":"2011","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26359","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201304000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:01:04Z","timestamp":1733137264000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201304000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26359","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}